Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal Cancers
Ruchi Shah(University of Wisconsin–Madison), Dustin A. Deming(University of Wisconsin–Madison)
Cited by 14
Related Papers
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
|Nature Reviews Clinical Oncology|2020|365
PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
|Oncogenesis|2015|75
Abstract CT028: A first-in-human phase 1 study of LY3537982, a highly selective and potent KRAS G12C inhibitor in patients with KRAS G12C-mutant advanced solid tumors
|Cancer Research|2023|37
Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K
|PLoS ONE|2016|22